Related Experiment Video
Updated: Jun 6, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA miR-125b causes leukemia
Marina Bousquet1, Marian H Harris, Beiyan Zhou
1Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Abstract:
MicroRNA miR-125b has been implicated in several kinds of leukemia. The chromosomal translocation t(2;11)(p21;q23) found in patients with myelodysplasia and acute myeloid leukemia leads to an overexpression of miR-125b of up to 90-fold normal. Moreover, miR-125b is also up-regulated in patients with B-cell acute lymphoblastic leukemia carrying the t(11;14)(q24;q32) translocation. To decipher the presumed oncogenic mechanism of miR-125b, we used transplantation experiments in mice. All mice transplanted with fetal liver cells ectopically expressing miR-125b showed an increase in white blood cell count, in particular in neutrophils and monocytes, associated with a macrocytic anemia. Among these mice, half died of B-cell acute lymphoblastic leukemia, T-cell acute lymphoblastic leukemia, or a myeloproliferative neoplasm, suggesting an important role for miR-125b in early hematopoiesis. Furthermore, coexpression of miR-125b and the BCR-ABL fusion gene in transplanted cells accelerated the development of leukemia in mice, compared with control mice expressing only BCR-ABL, suggesting that miR-125b confers a proliferative advantage to the leukemic cells. Thus, we show that overexpression of miR-125b is sufficient both to shorten the latency of BCR-ABL-induced leukemia and to independently induce leukemia in a mouse model.
Insights
MicroRNA miR-125b overexpression accelerates leukemia development. This study demonstrates miR-125b
Area of Science:
- Molecular Biology
- Hematology
- Oncology
Background:
- MicroRNA miR-125b is implicated in various leukemias.
- Chromosomal translocations like t(2;11) and t(11;14) lead to miR-125b overexpression in myelodysplasia, acute myeloid leukemia, and B-cell acute lymphoblastic leukemia.
- The precise oncogenic role of miR-125b in hematopoiesis requires further investigation.
Purpose of the Study:
- To investigate the oncogenic mechanism of miR-125b in hematopoiesis and leukemia development.
- To determine if miR-125b overexpression is sufficient to induce leukemia independently.
- To assess the impact of miR-125b on BCR-ABL-induced leukemia.
Main Methods:
- Transplantation experiments in mice using fetal liver cells.
- Ectopic expression of miR-125b in transplanted cells.
- Coexpression of miR-125b with the BCR-ABL fusion gene.
Main Results:
- Ectopic miR-125b expression increased white blood cell counts (neutrophils, monocytes) and caused macrocytic anemia.
- Half of the mice developed B-cell acute lymphoblastic leukemia, T-cell acute lymphoblastic leukemia, or myeloproliferative neoplasm.
- Coexpression with BCR-ABL accelerated leukemia development, indicating a proliferative advantage conferred by miR-125b.
Conclusions:
- Overexpression of miR-125b is sufficient to induce leukemia independently in a mouse model.
- miR-125b plays a significant role in early hematopoiesis.
- miR-125b shortens the latency of BCR-ABL-induced leukemia.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Induced Pluripotent Stem Cells
Somatic cells are...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

